STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
Abramson Cancer Center at Penn Medicine
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Washington University School of Medicine
Trishula Therapeutics, Inc.
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Massachusetts General Hospital
Cyteir Therapeutics, Inc.
Actuate Therapeutics Inc.
Zhejiang Provincial People's Hospital
Cedars-Sinai Medical Center
Celldex Therapeutics
OHSU Knight Cancer Institute
Corvus Pharmaceuticals, Inc.
Fate Therapeutics
Genzada Pharmaceuticals USA, Inc.
Blue Note Therapeutics
Hospital Universitario San Ignacio
Hospices Civils de Lyon
AstraZeneca
First Affiliated Hospital of Wenzhou Medical University
National Cancer Institute (NCI)
Tocagen Inc.
Shenzhen BinDeBio Ltd.
Tel-Aviv Sourasky Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
sigma-tau i.f.r. S.p.A.
Incyte Corporation
Celgene
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
INSYS Therapeutics Inc
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Alberta
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center